Homoeopathic intervention in preventing Dengue

Efficacy of Homoeopathic intervention Eupatorium perfoliatum 30 in preventing Dengue at urban slums of Delhi - cluster-randomized, double-blind, placebo-control trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090545

Enrollment

10000

Registered

2025-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Eupatorium perfoliatum 30: 02 pills in each dose of the Eupatorium perfoliatum 30, to be given per week from July to October to children. 04 pills in each dose of the Eupatorium perfoli

Eligibility

Inclusion criteria

Inclusion criteria: Voluntary written informed consent by the family head

Exclusion criteria

Exclusion criteria: Pregnant women and lactating mother Child below age of 1 year Individuals taking other preventive medicines for dengue. Patients with malignancy, immune-compromised state, life threatening diseases, end stage diseases. Symptom of acute febrile illness/ Dengue like illness at the time of enrolment. Patient with symptoms of acute infectious illnesses at the time of enrolment. Not willing to give written informed consent.

Design outcomes

Primary

Measure	Time frame
Incidence of Dengue between the groupsTimepoint: Weekly	—

Secondary

Measure	Time frame
Incidence of AUFI between the groupsTimepoint: Weekly;Changes/severity of symptoms between the groups during post prophylactic/ climatic infectionsTimepoint: at the time of analysis;Mean duration of acute febrile illnesses between the cohortsTimepoint: Weekly	—

Countries

India

Contacts

Public ContactDr Debadatta Nayak

Central Council for Research in Homoeopathy

drdnayak@gmail.com28525388

Outcome results